
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
12 | -0.08 | -24.2424242424 | 0.33 | 0.369 | 0.23 | 4718 | 0.29678832 | DE |
26 | -0.17 | -40.4761904762 | 0.42 | 0.89 | 0.22 | 29284 | 0.53203807 | DE |
52 | -4.15 | -94.3181818182 | 4.4 | 5.3 | 0.22 | 50926 | 0.8761504 | DE |
156 | -5.85 | -95.9016393443 | 6.1 | 11 | 0.22 | 19210 | 1.51030685 | DE |
260 | 0.066 | 35.8695652174 | 0.184 | 11 | 0.142 | 59539 | 1.257877 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.